
Sujay A Vora MD
Chair of the Department of Radiation Oncology, Mayo Clinic in Phoenix, Arizona
Join to view full profile
5881 E Mayo BlvdPhoenix, AZ 85054
Dr. Vora is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sujay A. Vora, M.D. is a radiation oncologist and both the residency program director and chair at Mayo Clinic Arizona’s Department of Radiation Oncology. He treats brain tumors, including low and high grade glioma, brain metastasis, acoustic neuroma, meningioma and pituitary adenomas. He also treats gynecologic cancers including endometrial, cervix and vulvar/vagina malignancies. His research interests include CNS malignancies and providing higher value care for his patients He is an assistant professor of Radiation Oncology at Mayo Clinic College of Medicine and Science. Dr. Vora received his medical degree at University of Pittsburgh and was chief resident at Tufts/Brown combined residency program. In 2012, U.S. News and World Report named him among the top doctors in America. U.S. News and World Report ranks Mayo Clinic Arizona the #1 hospital in the state.
Education & Training
Tufts Medical CenterResidency, Radiation Oncology, 1995 - 1999
Newton-Wellesley HospitalInternship, Internal Medicine, 1994 - 1995
University of Pittsburgh School of MedicineClass of 1994
Certifications & Licensure
AZ State Medical License 2000 - 2028
NM State Medical License 2025 - 2028
RI State Medical License 1999 - 2001
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification HealtheLife and FirstNet, Cerner Corporation, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification FirstNet (CQM), Cerner Corporation, 2013-2015, 2017
- CMS Meaningful Use Stage 1 Certification FirstNet, Cerner Corporation, 2013-2015, 2017
Clinical Trials
- Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors Start of enrollment: 2018 Nov 19
- 18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy Start of enrollment: 2019 Mar 28
Publications & Presentations
PubMed
- Dosimetric Comparison Between Brass Aperture-Enhanced Proton Pencil Beam Scanning and Photon Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations.Will Sperduto, Mattison J Flakus, Ed Clouser, Sujay A Vora, Jonathan B Ashman
International Journal of Particle Therapy. 2026-09-01 - Defining rapid early progression in glioblastoma-A volumetric approach.Vikram Munlapudi, Jacob Guzzino, David J Crompton, Shubhi Agarwal, Eric J Lehrer
Neuro-Oncology Advances. 2026-06-08 - Noisy probing dose facilitated dose prediction for pencil beam scanning proton therapy: Physics enhances generalizability.Lian Zhang, Jason M Holmes, Xiao Zhang, Zhengliang Liu, Hongying Feng
Medical Physics. 2026-05-01
Press Mentions
New Proton Beam Therapy Precisely Targets and Destroys Cancer CellsFebruary 19th, 2025
Video: Breakthrough in the Fight Against GlioblastomaJanuary 22nd, 2025
Breakthrough in Treatment Approach Showing Promise in the Fight Against GlioblastomaJanuary 16th, 2025
Committees
- Vice-Chair, Executive Committee Radiation Oncology 2019 - Present
- Residency Program Director, Education 2013 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









